Aug 28, 2024
Neola Medical has strengthened its management team, adding David Folkesson as the new CFO. He joins at an important stage for the company, which is currently preparing for clinical validation of Neola®. BioStock has contacted David to find out more about his...
Aug 26, 2024
“This is a step towards optimizing the conditions for a successful clinical study on preterm born infants in the U.S.”, says CEO anna Sjöström After recently obtaining the CB certificate for its medical device, Neola Medical is now intensively preparing...
Aug 23, 2024
The company’s product for continuous lung monitoring of preterm born infants is attracting significant international interest. Watch CEO Hanna Sjöström and CEO Oscar Ahlgren at Västra Hamnen TV discuss Neola Medical’s promising study data, the substantial...
Aug 16, 2024
The second quarter of 2024 marked several milestones towards achieving market approval in the U.S. Notably, the company’s medical device received CB certification, indicating that Neola®meets the required technical safety standards. Clinical trials are now on...
Aug 15, 2024
Did you miss all the exciting updates when CEO Hanna Sjöström and CFO Christian Gyllenberg presented Neola Medical’s Q2-report of 2024 at Finwire TV? Learn more about the company’s financial position and the important key achievements from this quarter, aimed at...
Jul 2, 2024
Hanna Sjöström’s career trajectory is impressive: first an international top career at Coca-Cola and L’Oréal, now CEO of a life-saving startup. Chefakademin’s Executive MBA is part of the recipe for success. “We developed the American launch strategy...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
